Cardiac transplantation: the final therapeutic option for the treatment of heart failure

被引:15
作者
Koerner, MM [1 ]
Durand, JB [1 ]
Lafuente, JA [1 ]
Noon, GP [1 ]
Torre-Amione, G [1 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1097/00001573-200005000-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
End-stage heart failure is still associated with a decrease in quality and prognosis of life. Cardiac transplantation remains the final extraordinary therapeutic option for the treatment of truly irreversible end-stage heart failure in all age groups. The selection process of candidates and the acceptance of patients with relative contra-indications is characterized by the experience and skills of an interdisciplinary transplant team, which should have access to different mechanical circulatory support systems for short-term or long-term use: bridging to transplant as well as for recovery. (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:178 / 182
页数:5
相关论文
共 37 条
  • [1] Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time
    Aaronson, KD
    Mancini, DM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (05) : 1189 - 1195
  • [2] Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure
    Auricchio, A
    Stellbrink, C
    Block, M
    Sack, S
    Vogt, J
    Bakker, P
    Klein, H
    Kramer, A
    Ding, J
    Salo, R
    Tockman, B
    Pochet, T
    Spinelli, J
    [J]. CIRCULATION, 1999, 99 (23) : 2993 - 3001
  • [3] Bartling B, 1999, CIRCULATION, V100, P216
  • [4] Heart transplantation in patients 70 years of age and older: Initial experience
    Blanche, C
    Matloff, JM
    Denton, TA
    Czer, LSC
    Fishbein, MC
    Takkenberg, JJM
    Trento, A
    [J]. ANNALS OF THORACIC SURGERY, 1996, 62 (06) : 1731 - 1736
  • [5] An analysis of the effect of age on survival after heart transplant
    Borkon, AM
    Muehlebach, GF
    Jones, PG
    Bresnahan, DR
    Genton, RE
    Gorton, ME
    Long, ND
    Magalski, A
    Porter, CB
    Reed, WA
    Rowe, SK
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (07) : 668 - 674
  • [6] DOSE-RESPONSE OF CHRONIC BETA-BLOCKER TREATMENT IN HEART-FAILURE FROM EITHER IDIOPATHIC DILATED OR ISCHEMIC CARDIOMYOPATHY
    BRISTOW, MR
    OCONNELL, JB
    GILBERT, EM
    FRENCH, WJ
    LEATHERMAN, G
    KANTROWITZ, NE
    ORIE, J
    SMUCKER, ML
    MARSHALL, G
    KELLY, P
    DEITCHMAN, D
    ANDERSON, JL
    [J]. CIRCULATION, 1994, 89 (04) : 1632 - 1642
  • [7] COSTANZO MR, SELECTION TREATMENT
  • [8] Safety and efficacy of a soluble P75 tumor necrosis factor receptor (enbrel, etanercept) in patients with advanced heart failure
    Deswal, A
    Bozkurt, B
    Seta, Y
    Parilti-Eiswirth, S
    Hayes, FA
    Blosch, C
    Mann, DL
    [J]. CIRCULATION, 1999, 99 (25) : 3224 - 3226
  • [9] TNF-α and heart failure -: The difference between proof of principle and hypothesis testing
    Francis, GS
    [J]. CIRCULATION, 1999, 99 (25) : 3213 - 3214
  • [10] Tumor necrosis factor-α -: A mediator of disease progression in the failing human heart
    Herrera-Garza, EH
    Stetson, SJ
    Cubillos-Garzon, A
    Vooletich, MT
    Farmer, JA
    Torre-Amione, G
    [J]. CHEST, 1999, 115 (04) : 1170 - 1174